Valneva SE is a speciality vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company current market three proprietary travel vaccines. From Wikipedia
U.S. health agencies recommend halting use of Valneva’s IXCHIQ vaccine in individuals aged 65 and older after reports of serious adverse events, while investigations continue.
